ORAI3 and Immunodeficiency: The same study places Orai3 as an important player in tumorigenesis in vivo, since the growth of breast tumors was significantly reduced by Orai3 knockdown before the transfer to the recipient mice with severe combined immunodeficiencies (SCID) [65].